Endothelial dysfunction and preeclampsia: Role of oxidative stress

Frontiers in Physiology

Volumn 5, Issue OCT, 2014, Pages

  Sánchez Aranguren, Lissette C ^a,b   Prada, Carlos E ^a,c   Riaño Medina, Carlos E ^a   Lopez, Marcos ^a,b  

^a Cardiovascular Foundation of Colombia   (Colombia)

^b UNIVERSIDAD DEL VALLE   (Colombia)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Endothelial dysfunction; Oxidative stress; Preeclampsia; Reactive oxygen species; Superoxide

Indexed keywords

EID: 84949115792     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00372     Document Type: Review

References (136)

1. Aydin, S., Benian, A., Madazli, R., Uludag, S., Uzun, H., and Kaya, S. (2004). Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 113, 21-25. doi: 10.1016/S0301-2115(03)00368-3
2. Babior, B. M. (2004). NADPH oxidase. Curr. Opin. Immunol. 16, 42-47. doi: 10.1016/j.coi.2003.12.001
3. Bainbridge, S. A., Deng, J. S., and Roberts, J. M. (2009). Increased xanthine oxidase in the skin of preeclamptic women. Reprod. Sci. 16, 468-478. doi: 10.1177/1933719108329817
4. Baker, P. N., Davidge, S. T., and Roberts, J. M. (1995). Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension 26, 244-248.
5. Barker, D. J., and Osmond, C. (1986). Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1, 1077-1081.
6. Bartesaghi, S., Peluffo, G., Zhang, H., Joseph, J., Kalyanaraman, B., and Radi, R. (2008). Tyrosine nitration, dimerization, and hydroxylation by peroxynitrite in membranes as studied by the hydrophobic probe N-t-BOC-l-tyrosine tert-butyl ester. Meth. Enzymol. 441, 217-236. doi: 10.1016/s0076-6879(08)01212-3
7. Bartesaghi, S., Valez, V., Trujillo, M., Peluffo, G., Romero, N., Zhang, H., et al. (2006). Mechanistic studies of peroxynitrite-mediated tyrosine nitration in membranes using the hydrophobic probe N-t-BOC-L-tyrosine tert-butyl ester. Biochemistry 45, 6813-6825. doi: 10.1021/bi060363x
8. Bartesaghi, S., Wenzel, J., Trujillo, M., Lopez, M., Joseph, J., Kalyanaraman, B., et al. (2010). Lipid peroxyl radicals mediate tyrosine dimerization and nitration in membranes. Chem. Res. Toxicol. 23, 821-835. doi: 10.1021/tx900446r
9. Beckman, J. S., and Koppenol, W. H. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424-C1437.
10. Bilodeau, J. F. (2014). Review: maternal and placental antioxidant response to preeclampsia - Impact on vasoactive eicosanoids. Placenta 35, S32-S38. doi: 10.1016/j.placenta.2013.11.013
11. Bisseling, T. M., Maria Roes, E., Raijmakers, M. T., Steegers, E. A., Peters, W. H., and Smits, P. (2004). N-acetylcysteine restores nitric oxide-mediated effects in the fetoplacental circulation of preeclamptic patients. Am. J. Obstet. Gynecol. 191, 328-333. doi: 10.1016/j.ajog.2003.12.033
12. Cao, C., O'brien, K. O., Arroyo, P., Pardio, J., and Loria, A. (2013). Pregnancy and iron homeostasis: an update. special issue: iron deficiency and iron deficiency anemia in early infancy; etiology, consequences, prevalence, and prevention. foreword. Nutr. Rev. 71, 35-51. doi: 10.1111/j.1753-4887.2012.00550.x
13. Chen, Q., Tong, M., Wu, M., Stone, P. R., Snowise, S., and Chamley, L. W. (2013). Calcium supplementation prevents endothelial cell activation: possible relevance to preeclampsia. J. Hypertens. 31, 1828-1836. doi: 10.1097/HJH.0b013e328362ba1a
14. Choi, J. W., Im, M. W., and Pai, S. H. (2002). Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann. Clin. Lab. Sci. 32, 257-263.
15. Choi, S., Kim, J. A., Na, H. Y., Kim, J. E., Park, S., Han, K. H., et al. (2013). NADPH oxidase 2-derived superoxide downregulates endothelial KCa3.1 in preeclampsia. Free Radic. Biol. Med. 57, 10-21. doi: 10.1016/j.freeradbiomed.2012.12.009
16. Colleoni, F., Padmanabhan, N., Yung, H. W., Watson, E. D., Cetin, I., Tissot Van Patot, M. C., et al. (2013). Suppression of mitochondrial electron transport chain function in the hypoxic human placenta: a role for miRNA-210 and protein synthesis inhibition. PLoS ONE 8:e55194. doi: 10.1371/journal.pone.0055194
17. Conrad, K. P., and Davis, A. K. (1995). Nitric oxide synthase activity in placentae from women with pre-eclampsia. Placenta 16, 691-699. doi: 10.1016/0143-4004(95)90013-6
18. Conrad, K. P., Kerchner, L. J., and Mosher, M. D. (1999). Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am. J. Physiol. 277, F48-F57.
19. Cui, X. L., Brockman, D., Campos, B., and Myatt, L. (2006). Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 27, 422-431. doi: 10.1016/j.placenta.2005.04.004
20. Das, B., Saha-Roy, S., Das Gupta, A., Lahiri, T. K., and Das, H. N. (2012). Assessment of placental oxidative stress in pre-eclampsia. J. Obstet. Gynaecol. India 62, 39-42. doi: 10.1007/s13224-012-0150-z
21. Davidge, S. T., Baker, P. N., and Roberts, J. M. (1995). NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am. J. Physiol. 269, H1106-H1112.
22. Davidge, S. T., Stranko, C. P., and Roberts, J. M. (1996). Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am. J. Obstet. Gynecol. 174, 1008-1013.
23. Dechend, R., Viedt, C., Müller, D. N., Ugele, B., Brandes, R. P., Wallukat, G., et al. (2003). AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107, 1632-1639. doi: 10.1161/01.cir.0000058200.90059.b1
24. Desai, M., and Hales, C. N. (1997). Role of fetal and infant growth in programming metabolism in later life. Biol. Rev. Camb. Philos. Soc. 72, 329-348.
25. Diejomaoh, F. M., Omu, A. E., Al-Busiri, N., Taher, S., Al-Othman, S., Fatinikun, T., et al. (2004). Nitric oxide production is not altered in preeclampsia. Arch. Gynecol. Obstet. 269, 237-243. doi: 10.1007/s00404-002-0465-6
26. Duvekot, J. J., Cheriex, E. C., Pieters, F. A., Menheere, P. P., and Peeters, L. H. (1993). Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am. J. Obstet. Gynecol. 169, 1382-1392.
27. Ehsanipoor, R. M., Fortson, W., Fitzmaurice, L. E., Liao, W. X., Wing, D. A., Chen, D. B., et al. (2013). Nitric oxide and carbon monoxide production and metabolism in preeclampsia. Reprod. Sci. 20, 542-548. doi: 10.1177/1933719112459231
28. Eis, A. L., Brockman, D. E., Pollock, J. S., and Myatt, L. (1995). Immunohistochemical localization of endothelial nitric oxide synthase in human villous and extravillous trophoblast populations and expression during syncytiotrophoblast formation in vitro. Placenta 16, 113-126.
29. Eskenazi, B., Fenster, L., and Sidney, S. (1991). A multivariate analysis of risk factors for preeclampsia. JAMA 266, 237-241.
30. Garcia, R. G., Celedon, J., Sierra-Laguado, J., Alarcon, M. A., Luengas, C., Silva, F., et al. (2007). Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am. J. Hypertens. 20, 98-103. doi: 10.1016/j.amjhyper.2006.06.001
31. Genc, H., Uzun, H., Benian, A., Simsek, G., Gelisgen, R., Madazli, R., et al. (2011). Evaluation of oxidative stress markers in first trimester for assessment of preeclampsia risk. Arch. Gynecol. Obstet. 284, 1367-1373. doi: 10.1007/s00404-011-1865-2
32. Godfrey, K., Robinson, S., Barker, D. J., Osmond, C., and Cox, V. (1996). Maternal nutrition in early and late pregnancy in relation to placental and fetal growth. BMJ 312, 410-414.
33. Gonzalez-Garrido Chem, J. A., Olivares-Corichi, I. M., Tovar-Rodriguez, J. M., Hernandez-Santana, N. A., Mendez-Bolaina, E., Ceballos-Reyes, G. M., et al. (2013). Influence of the AT(2) receptor on the L-arginine-nitric oxide pathway and effects of (-)-epicatechin on HUVECs from women with preeclampsia. J. Hum. Hypertens. 27, 355-361. doi: 10.1038/jhh.2012.55
34. Harper, M., Thom, E., Klebanoff, M. A., Thorp, J. Jr. Sorokin, Y., Varner, M. W., et al. (2010). Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstet. Gynecol. 115, 234-242. doi: 10.1097/AOG.0b013e3181cbd60e
35. Hofmeyr, G. J., Lawrie, T. A., Atallah, A. N., Duley, L., and Torloni, M. R. (2014). Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst. Rev. 6:CD001059. doi: 10.1002/14651858.CD001059.pub4
36. Hung, T. H., Chen, S. F., Hsieh, C. C., Hsu, J. J., Li, M. J., Yeh, Y. L., et al. (2008). Tumor necrosis factor-alpha converting enzyme in the human placenta throughout gestation. Reprod. Sci. 15, 195-209. doi: 10.1177/1933719107310709
37. Hunkapiller, N. M., and Fisher, S. J. (2008). Chapter 12. placental remodeling of the uterine vasculature. Methods Enzymol. 445, 281-302. doi: 10.1016/S0076-6879(08)03012-7
38. Jialal, I., Verma, S., and Devaraj, S. (2009). Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance. Clin. Chem. 55, 206-208. doi: 10.1373/clinchem.2008.119206
39. Jones, M. L., Mark, P. J., Mori, T. A., Keelan, J. A., and Waddell, B. J. (2013). Maternal dietary omega-3 fatty acid supplementation reduces placental oxidative stress and increases fetal and placental growth in the rat. Biol. Reprod. 88, 37. doi: 10.1095/biolreprod.112.103754
40. Kalyanaraman, B. (2013). Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms. Redox Biol. 1, 244-257. doi: 10.1016/j.redox.2013.01.014
41. Karacay, O., Sepici-Dincel, A., Karcaaltincaba, D., Sahin, D., Yalvac, S., Akyol, M., et al. (2010). A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Res. Clin. Pract. 89, 231-238. doi: 10.1016/j.diabres.2010.04.015
42. Karbach, S., Wenzel, P., Waisman, A., Munzel, T., and Daiber, A. (2014). eNOS uncoupling in cardiovascular diseases-the role of oxidative stress and inflammation. Curr. Pharm. Des. 20, 3579-3594. doi: 10.2174/13816128113196660748
43. Karthikeyan, V. J., and Lip, G. Y. (2011). Endothelial damage/dysfunction and hypertension in pregnancy. Front. Biosci. (Elite. Ed). 3, 1100-1108. doi: 10.2741/314
44. Khalil, A. A., Tsikas, D., Akolekar, R., Jordan, J., and Nicolaides, K. H. (2013). Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks' gestation and preeclampsia: a case-control study. J. Hum. Hypertens. 27, 38-43. doi: 10.1038/jhh.2011.109
45. Kharb, S., Gulati, N., Singh, V., and Singh, G. P. (2000). Superoxide anion formation and glutathione levels in patients with preeclampsia. Gynecol. Obstet. Invest. 49, 28-30. doi: 10.1159/000010208
46. Kim, Y. J., Park, H. S., Lee, H. Y., Ha, E. H., Suh, S. H., Oh, S. K., et al. (2006). Reduced l-arginine level and decreased placental eNOS activity in preeclampsia. Placenta 27, 438-444. doi: 10.1016/j.placenta.2005.04.011
47. Kinney, M. V., Lawn, J. E., Howson, C. P., and Belizan, J. (2012). 15 Million preterm births annually: what has changed this year? Reprod. Health 9:28. doi: 10.1186/1742-4755-9-28
48. Kukor, Z., Valent, S., and Toth, M. (2000). Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies. Placenta 21, 763-772. doi: 10.1053/plac.2000.0584
49. Lain, K. Y., and Roberts, J. M. (2002). Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287, 3183-3186. doi: 10.1001/jama.287.24.3183
50. Lappas, M., Mitton, A., and Permezel, M. (2010). In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. J. Endocrinol. 204, 75-84. doi: 10.1677/JOE-09-0321
51. Lee, V. M., Quinn, P. A., Jennings, S. C., and Ng, L. L. (2003). NADPH oxidase activity in preeclampsia with immortalized lymphoblasts used as models. Hypertension 41, 925-931. doi: 10.1161/01.hyp.0000062021.68464.9d
52. Liu, L., Johnson, H. L., Cousens, S., Perin, J., Scott, S., Lawn, J. E., et al. (2012). Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379, 2151-2161. doi: 10.1016/s0140-6736(12)60560-1
53. López-Jaramillo, P. (1996). Prevention of preeclampsia with calcium supplementation and its relation with the L-arginine:nitric oxide pathway. Braz. J. Med. Biol. Res. 29, 731-741.
54. López-Jaramillo, P., Arenas, W. D., García, R. G., Rincon, M. Y., and López, M. (2008). Review: the role of the L-arginine-nitric oxide pathway in preeclampsia. Ther. Adv. Cardiovasc. Dis. 2, 261-275. doi: 10.1177/1753944708092277
55. López-Jaramillo, P., Garcia, R. G., and Lopez, M. (2005). Preventing pregnancy-induced hypertension: are there regional differences for this global problem? J. Hypertens. 23, 1121-1129. doi: 10.1097/01.hjh.0000170371.49010.4a
56. López-Jaramillo, P., and López-López, J. (2010). Fetal programming and cardiometabolic diseases: the role of angiotensin II and inflammation. Clín. Invest. Arterioscler. 22(Suppl. 2), 21-24. doi: 10.1016/S0214-9168(10)70030-9
57. López-Novoa, J. M. (2007). Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia. Nephrol. Dial. Transplant 22, 712-714. doi: 10.1093/ndt/gfl768
58. Luttun, A., Tjwa, M., and Carmeliet, P. (2002). Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann. N.Y. Acad. Sci. 979, 80-93. doi: 10.1111/j.1749-6632.2002.tb04870.x
59. Lyall, F., Robson, S. C., and Bulmer, J. N. (2013). Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 62, 1046-1054. doi: 10.1161/HYPERTENSIONAHA.113.01892
60. Lyall, F., Young, A., and Greer, I. A. (1995). Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am. J. Obstet. Gynecol. 173, 714-718
61. Maas, R., Boger, R. H., Schwedhelm, E., Casas, J. P., Lopez-Jaramillo, P., Serrano, N., et al. (2004). Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia. JAMA 291, 823-824. doi: 10.1001/jama.291.7.823
62. Maloyan, A., Mele, J., Muralimanohara, B., and Myatt, L. (2012). Measurement of mitochondrial respiration in trophoblast culture. Placenta 33, 456-458. doi: 10.1016/j.placenta.2012.01.016
63. Mandò, C., De Palma, C., Stampalija, T., Anelli, G. M., Figus, M., Novielli, C., et al. (2014). Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. Am. J. Physiol. Endocrinol. Metab. 306, E404-E413. doi: 10.1152/ajpendo.00426.2013
64. Many, A., Hubel, C. A., Fisher, S. J., Roberts, J. M., and Zhou, Y. (2000). Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am. J. Pathol. 156, 321-331. doi: 10.1016/s0002-9440(10)64733-5
65. Many, A., Hubel, C. A., and Roberts, J. M. (1996). Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am. J. Obstet. Gynecol. 174, 288-291.
66. Mao, D., Che, J., Li, K., Han, S., Yue, Q., Zhu, L., et al. (2010). Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Arch. Gynecol. Obstet. 282, 371-375. doi: 10.1007/s00404-009-1234-6
67. Maranzana, E., Barbero, G., Falasca, A. I., Lenaz, G., and Genova, M. L. (2013). Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I. Antioxid. Redox Signal. 19, 1469-1480. doi: 10.1089/ars.2012.4845
68. Matsubara, K., Matsubara, Y., Hyodo, S., Katayama, T., and Ito, M. (2010). Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. J. Obstet. Gynaecol. Res. 36, 239-247. doi: 10.1111/j.1447-0756.2009.01128.x
69. Matsubara, S., and Sato, I. (2001). Enzyme histochemically detectable NAD(P)H oxidase in human placental trophoblasts: normal, preeclamptic, and fetal growth restriction-complicated pregnancy. Histochem. Cell Biol. 116, 1-7. doi: 10.1007/s004180100301
70. Mayeur, S., Lancel, S., Theys, N., Lukaszewski, M. A., Duban-Deweer, S., Bastide, B., et al. (2013). Maternal calorie restriction modulates placental mitochondrial biogenesis and bioenergetic efficiency: putative involvement in fetoplacental growth defects in rats. Am. J. physiol. Endocrinol. metab. 304, E14-E22. doi: 10.1152/ajpendo.00i332.2012
71. Maynard, S. E., Min, J. Y., Merchan, J., Lim, K. H., Li, J., Mondal, S., et al. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658. doi: 10.1172/jci17189
72. Mills, T. A., Wareing, M., Shennan, A. H., Poston, L., Baker, P. N., and Greenwood, S. L. (2009). Acute and chronic modulation of placental chorionic plate artery reactivity by reactive oxygen species. Free Radic. Biol. Med. 47, 159-166. doi:' 10.1016/j.freeradbiomed.2009.04.019
73. Mitchell, B. M., Cook, L. G., Danchuk, S., and Puschett, J. B. (2007). Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertensionast. Am. J. Hypertens. 20, 1297-1304. doi: 10.1016/j.amjhyper.2007.08.007
74. Moncada, S., and Higgs, A. (1993). The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012. doi: 10.1056/nejm199312303292706
75. Moncada, S., Palmer, R. M., and Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
76. Monteiro, C. A., Moura, E. C., Conde, W. L., and Popkin, B. M. (2004). Socioeconomic status and obesity in adult populations of developing countries: a review. Bull. World Health Organ. 82, 940-946.
77. Muralimanoharan, S., Maloyan, A., Mele, J., Guo, C., Myatt, L. G., and Myatt, L. (2012). MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 33, 816-823. doi: 10.1016/j.placenta.2012.07.002
78. Murphy, S. R., Lamarca, B. B., Parrish, M., Cockrell, K., and Granger, J. P. (2013). Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-alpha. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R130-R135. doi: 10.1152/ajpregu.00069.2012
79. Mutinati, M., Piccinno, M., Roncetti, M., Campanile, D., Rizzo, A., and Sciorsci, R. (2013). Oxidative stress during pregnancy in the sheep. Reprod. Domest. Anim. 48, 353-357. doi: 10.1111/rda.12141
80. Myatt, L. (2010). Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 31(Suppl), S66-S69. doi: 10.1016/j.placenta.2009.12.021
81. Myatt, L., and Cui, X. (2004). Oxidative stress in the placenta. Histochem. Cell Biol. 122, 369-382. doi: 10.1007/s00418-004-0677-x
82. Myatt, L., and Webster, R. P. (2009). Vascular biology of preeclampsia. J. Thromb. Haemost. 7, 375-384. doi: 10.1111/j.1538-7836.2008.03259.x
83. Nagamatsu, T., Fujii, T., Kusumi, M., Zou, L., Yamashita, T., Osuga, Y., et al. (2004). Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145, 4838-4845. doi: 10.1210/en.2004-0533
84. Nakatsukasa, Y., Tsukahara, H., Tabuchi, K., Tabuchi, M., Magami, T., Yamada, M., et al. (2013). Thioredoxin-1 and oxidative stress status in pregnant women at early third trimester of pregnancy: relation to maternal and neonatal characteristics. J. Clin. Biochem. Nutr. 52, 27-31. doi: 10.3164/jcbn.12-71
85. Nishikawa, S., Miyamoto, A., Yamamoto, H., Ohshika, H., and Kudo, R. (2000). The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia. Life Sci. 67, 1447-1454. doi: 10.1016/S0024-3205(00)00736-0
86. Nobunaga, T., Tokugawa, Y., Hashimoto, K., Kimura, T., Matsuzaki, N., Nitta, Y., et al. (1996). Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol. Obstet. Invest. 41, 189-193.
87. North, R. A., McCowan, L. M., Dekker, G. A., Poston, L., Chan, E. H., Stewart, A. W., et al. (2011). Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ 342:d1875. doi: 10.1136/bmj.d1875
88. Palmer, R. M., Ashton, D. S., and Moncada, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333, 664-666. doi: 10.1038/333664a0
89. Pathak, N., Sawhney, H., Vasishta, K., and Majumdar, S. (1999). Estimation of oxidative products of nitric oxide (nitrates, nitrites) in preeclampsia. Aust. N. Z. J. Obstet. Gynaecol. 39, 484-487.
90. Pimentel, A. M. L., Pereira, N. R., Costa, C. A., Mann, G. E., Cordeiro, V. S. C., De Moura, R. S., et al. (2013). L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia. Hypertens. Res. 36, 783-788. doi: 10.1038/hr.2013.34
91. Poston, L., Igosheva, N., Mistry, H. D., Seed, P. T., Shennan, A. H., Rana, S., et al. (2011). Role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am. J. Clin. Nutr. 94, 1980S-1985S. doi: 10.3945/ajcn.110.001156
92. Qian, J., and Fulton, D. (2013). Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium. Front. Physiol. 4:347. doi: 10.3389/fphys.2013.00347
93. Radi, R. (2004). Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. U.S.A. 101, 4003-4008. doi: 10.1073/pnas.0307446101
94. Raijmakers, M. T., Peters, W. H., Steegers, E. A., and Poston, L. (2004). NAD(P)H oxidase associated superoxide production in human placenta from normotensive and pre-eclamptic women. Placenta 25(Suppl. A), S85-S89. doi: 10.1016/j.placenta.2004.01.009
95. Redman, C. W. (1991). Current topic: pre-eclampsia and the placenta. Placenta 12, 301-308.
96. Redman, C. W., and Sargent, I. L. (2003). Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 24(Suppl A), S21-S27. doi: 10.1053/plac.2002.0930
97. Redman, C. W., and Sargent, I. L. (2005). Latest advances in understanding preeclampsia. Science 308, 1592-1594. doi: 10.1126/science.1111726
98. Roberts, J. M., Balk, J. L., Bodnar, L. M., Belizan, J. M., Bergel, E., and Martinez, A. (2003). Nutrient involvement in preeclampsia. J. Nutr. 133, 1684S-1692S.
99. Roberts, J. M., Myatt, L., Spong, C. Y., Thom, E. A., Hauth, J. C., Leveno, K. J., et al. (2010). Vitamins C and E to prevent complications of pregnancy-associated hypertension. N. Engl. J. Med. 362, 1282-1291. doi: 10.1056/NEJMoa0908056
100. Roberts, J. M., Taylor, R. N., and Goldfien, A. (1991). Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am. J. Hypertens. 4, 700-708.
101. Roberts, V. H., Smith, J., McLea, S. A., Heizer, A. B., Richardson, J. L., and Myatt, L. (2009). Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta 30, 169-175. doi: 10.1016/j.placenta.2008.11.019
102. Roes, E. M., Raijmakers, M. T., Boo, T. M., Zusterzeel, P. L., Merkus, H. M., Peters, W. H., et al. (2006). Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 127, 61-67. doi: 10.1016/j.ejogrb.2005.09.007
103. Rumbold, A., Duley, L., Crowther, C. A., and Haslam, R. R. (2008). Antioxidants for preventing pre-eclampsia. Cochrane Database Syst. Rev. CD004227. doi: 10.1002/14651858.CD004227.pub3
104. Saito, S., and Nakashima, A. (2014). A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling. J. Reprod. Immunol. 101-102, 80-88. doi: 10.1016/j.jri.2013.06.002
105. Salles, A. M., Galvao, T. F., Silva, M. T., Motta, L. C., and Pereira, M. G. (2012). Antioxidants for preventing preeclampsia: a systematic review. ScientificWorldJournal. 2012:243476. doi: 10.1100/2012/243476
106. Sandrim, V. C., Palei, A. C., Metzger, I. F., Cavalli, R. C., Duarte, G., and Tanus-Santos, J. E. (2010). Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia. Clin. Chim. Acta 411, 1457-1460. doi: 10.1016/j.cca.2010.05.039
107. Sato, Y., Kanno, S., Oda, N., Abe, M., Ito, M., Shitara, K., et al. (2000). Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann. N.Y. Acad. Sci. 902, 201-205. discussion: 205-207. doi: 10.1111/j.1749-6632.2000.tb06314.x
108. Savvidis, A., Daniilidis, A., Giannoulis, C., Tantanasis, T., Koiou, K., Zournatzi, V., et al. (2011). Correlation between asymmetric dimethylarginine maternal plasma levels and preeclampsia. Clin. Exp. Obstet. Gynecol. 38, 134-136.
109. Seligman, S. P., Buyon, J. P., Clancy, R. M., Young, B. K., and Abramson, S. B. (1994). The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol. 171, 944-948.
110. Shaamash, A. H., Elsnosy, E. D., Makhlouf, A. M., Zakhari, M. M., Ibrahim, O. A., and Hm, E. L.-D. (2000). Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int. J. Gynaecol. Obstet. 68, 207-214. doi: 10.1016/S0020-7292(99)00213-1
111. Shi, Z., Long, W., Zhao, C., Guo, X., Shen, R., and Ding, H. (2013). Comparative proteomics analysis suggests that placental mitochondria are involved in the development of pre-eclampsia. PLoS ONE 8:e64351. doi: 10.1371/journal.pone.0064351
112. Sibai, B. M., Ewell, M., Levine, R. J., Klebanoff, M. A., Esterlitz, J., Catalano, P. M., et al. (1997). Risk factors associated with preeclampsia in healthy nulliparous women. The calcium for Preeclampsia Prevention (CPEP) Study Group. Am. J. Obstet. Gynecol. 177, 1003-1010.
113. Singh, U., Devaraj, S., Vasquez-Vivar, J., and Jialal, I. (2007). C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J. Mol. Cell. Cardiol. 43, 780-791. doi: 10.1016/j.yjmcc.2007.08.015
114. Skoczylas-Pietrzyk, M., Stryjecka-Zimmer, M., and Oleszczuk, J. (1998). [Lipid and protein peroxidation process and catalase activity in pre-eclamptic placenta]. Ginekol. Pol. 69, 902-908.
115. Sorokin, Y., Romero, R., Mele, L., Wapner, R. J., Iams, J. D., Dudley, D. J., et al. (2010). Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. Am. J. Perinatol. 27, 631-640. doi: 10.1055/s-0030-1249366
116. Teran, E., Escudero, C., and Moya, W. (2006). Abnormal release of nitric oxide from nitrosoprotein in preeclampsia. Int. J. Gynaecol. Obstet. 92, 260-261. doi: 10.1016/j.ijgo.2005.12.015
117. Teran, E., Escudero, C., Moya, W., Flores, M., Vallance, P., and Lopez-Jaramillo, P. (2001). Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int. J. Gynaecol. Obstet. 75, 243-249. doi: 10.1016/S0020-7292(01)00499-4
118. Torbergsen, T., Oian, P., Mathiesen, E., and Borud, O. (1989). Pre-eclampsia-a mitochondrial disease? Acta Obstet. Gynecol. Scand. 68, 145-148.
119. Tortladze, M., Kintraia, N., Parkauli, M., and Sanikidze, T. (2013). Blood antioxidant enzyme activity during physiological and preeclampsia syndrome complicated pregnancy. Georgian Med. News. 215, 12-16.
120. Valerio, A., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Pisconti, A., et al. (2006). TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J. Clin. Invest. 116, 2791-2798. doi: 10.1172/JCI28570
121. Vasquez-Vivar, J., Kalyanaraman, B., and Martasek, P. (2003). The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic. Res. 37, 121-127. doi: 10.1080/1071576021000040655
122. Verlohren, S., Geusens, N., Morton, J., Verhaegen, I., Hering, L., Herse, F., et al. (2010). Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy. Hypertension 56, 304-310. doi: 10.1161/HYPERTENSIONAHA.110.153163
123. Vural, P. (2002). Nitric oxide/endothelin-1 in preeclampsia. Clin. Chim. Acta 317, 65-70. doi: 10.1016/S0009-8981(01)00751-3
124. Wakefield, S. L., Lane, M., and Mitchell, M. (2011). Impaired mitochondrial function in the preimplantation embryo perturbs fetal and placental development in the mouse. Biol. Reprod. 84, 572-580. doi: 10.1095/biolreprod.110.087262
125. Walker, J. J. (2000). Pre-eclampsia. Lancet 356, 1260-1265. doi: 10.1016/S0140-6736(00)02800-2
126. Webster, R. P., Brockman, D., and Myatt, L. (2006a). Nitration of p38 MAPK in the placenta: association of nitration with reduced catalytic activity of p38 MAPK in pre-eclampsia. Mol. Hum. Reprod. 12, 677-685. doi: 10.1093/molehr/gal071
127. Webster, R. P., Macha, S., Brockman, D., and Myatt, L. (2006b). Peroxynitrite treatment in vitro disables catalytic activity of recombinant p38 MAPK. Proteomics 6, 4838-4844. doi: 10.1002/pmic.200600176
128. Webster, R. P., Roberts, V. H., and Myatt, L. (2008). Protein nitration in placenta - functional significance. Placenta 29, 985-994. doi: 10.1016/j.placenta.2008.09.003
129. Weissgerber, T. L., Gandley, R. E., McGee, P. L., Spong, C. Y., Myatt, L., Leveno, K. J., et al. (2013). Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population. PLoS ONE 8:e60479. doi: 10.1371/journal.pone.0060479
130. Widmer, M., Villar, J., Benigni, A., Conde-Agudelo, A., Karumanchi, S. A., and Lindheimer, M. (2007). Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet. Gynecol. 109, 168-180. doi: 10.1097/01.AOG.0000249609.04831.7c
131. Yang, X., Guo, L., Li, H., Chen, X., and Tong, X. (2012). Analysis of the original causes of placental oxidative stress in normal pregnancy and pre-eclampsia: a hypothesis. J. Matern. Fetal Neonatal Med. 25, 884-888. doi: 10.3109/14767058.2011.601367
132. Yildirim, A., Altinkaynak, K., Aksoy, H., Sahin, Y. N., and Akcay, F. (2004). Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia. Cell Biochem. Funct. 22, 213-217. doi: 10.1002/cbf.1090
133. Yiyenoğlu, Ö. B., Uğur, M. G., Özcan, H. S. C., Can, G., Özturk, E., Balat, Ö., et al. (2013). Assessment of oxidative stress markers in recurrent pregnancy loss: a prospective study. Arch. Gynecol. Obstet. 289, 1337-1340. doi: 10.1007/s00404-013-3113-4
134. Yzydorczyk, C., Comte, B., Huyard, F., Cloutier, A., Germain, N., Bertagnolli, M., et al. (2013). Developmental programming of eNOS uncoupling and enhanced vascular oxidative stress in adult rats after transient neonatal oxygen exposure. J. Cardiovasc. Pharmacol. 61, 8-16. doi: 10.1097/FJC.0b013e318274d1c4
135. Zarubin, T., and Han, J. (2005). Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15, 11-18. doi: 10.1038/sj.cr.7290257
136. Zhou, Q., Qiao, F. Y., Zhao, C., and Liu, H. Y. (2011). Hypoxic trophoblast-derived sFlt-1 may contribute to endothelial dysfunction: implication for the mechanism of trophoblast-endothelial dysfunction in preeclampsia. Cell Biol. Int. 35, 61-66. doi: 10.1042/CBI20100020